Table 2.

Details of Gender-Affirming Hormone Therapy Used (n = 31)

Category	Value
Prescribed GAHT at study entry, No. (%)	13 (22.03)
Prescribed GAHT at any point, No. (%)	31 (52.54)
GAHT type (n = 31), No. (%)
Estrogen	27 (87.10)
Progesterone	2 (6.45)
Combination	2 (6.45)
Anti-androgen (n = 27), No. (%)	21 (70)
Virally suppressed at GAHT initiation (n = 22),a No. (%)	19 (86.36)

Abbreviations: GAHT, gender-affirming hormone therapy; HRT, hormone replacement therapy.

^aDefined as viral load <200 copies/mL at the time of HRT initiation when viral load data were available.